In this regard, it has been demonstrated that blocking PD-1/PD-L1 interaction with an anti-PD-1 antibody is beneficial for the treatment of various types of cancer (particularly in the case of melanoma) (7, 8). This evidence concerns the gene CD274 and melanoma.